REVEFENACIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | REVEFENACIN |
| DrugBank ID | DB11855 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 23 |
| DL Predictions (≥0.7) | 27 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| overactive bladder (disease) | TxGNN Knowledge Graph | L5 |
| parkinson disease | TxGNN Knowledge Graph | L5 |
| parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph | L5 |
| hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph | L5 |
| focal hand dystonia | TxGNN Knowledge Graph | L5 |
| juvenile onset parkinson disease 19a | TxGNN Knowledge Graph | L5 |
| early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph | L5 |
| atypical juvenile parkinsonism | TxGNN Knowledge Graph | L5 |
| postencephalitic parkinson disease | TxGNN Knowledge Graph | L5 |
| basal ganglia disease | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11